Connor M O'Rielly1, James E Andruchow1, Andrew D McRae2. 1. Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Room 3E34, Calgary, AB, T2N 4Z6, Canada. 2. Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Room 3E34, Calgary, AB, T2N 4Z6, Canada. amcrae@ucalgary.ca.
Abstract
BACKGROUND: The history, ECG, age, risk factor (HEAR) score has been proposed to identify patients at sufficiently low risk of acute coronary syndrome that they may not require troponin testing. The objective of this study was to externally validate a low HEAR score to identify emergency department (ED) patients with chest pain at very low risk of 30-day major adverse cardiac events (MACE). METHODS: This was a secondary analysis of a prospective cohort of patients requiring troponin testing to rule out myocardial infarction (MI) in a large urban ED. HEAR scores were calculated in two cohorts: (1) patients with no known history of coronary artery disease (CAD); and (2) all eligible patients. The proportion of patients classified as very low risk, sensitivity, specificity, predictive values and likelihood ratios at each cut-off were quantified for index acute myocardial infarction (AMI) and 30-day MACE at HEAR = 0 and HEAR ≤ 1 thresholds. RESULTS: Of the 1150 patients included in this study, 820 (71.3%) had no history of CAD, 97 (8.4%) had index AMI and 123 (10.7%) had 30-day MACE. In patients with no prior history of CAD, HEAR ≤ 1 identified 202 (24.6%) of patients as very low risk for 30-day MACE with 98.4% (95% CI 91.6-99.9%) sensitivity. Among all patients, HEAR ≤ 1 identified 202 (17.6%) patients as very low risk for 30-day MACE with 99.2% (95% CI 95.6-99.9%) sensitivity. CONCLUSIONS: A HEAR score ≤ 1 can identify more than 17% of all patients as very low risk for index AMI and 30-day MACE and unlikely to benefit from troponin testing. Broad implementation of this strategy could lead to significant resource savings.
BACKGROUND: The history, ECG, age, risk factor (HEAR) score has been proposed to identify patients at sufficiently low risk of acute coronary syndrome that they may not require troponin testing. The objective of this study was to externally validate a low HEAR score to identify emergency department (ED) patients with chest pain at very low risk of 30-day major adverse cardiac events (MACE). METHODS: This was a secondary analysis of a prospective cohort of patients requiring troponin testing to rule out myocardial infarction (MI) in a large urban ED. HEAR scores were calculated in two cohorts: (1) patients with no known history of coronary artery disease (CAD); and (2) all eligible patients. The proportion of patients classified as very low risk, sensitivity, specificity, predictive values and likelihood ratios at each cut-off were quantified for index acute myocardial infarction (AMI) and 30-day MACE at HEAR = 0 and HEAR ≤ 1 thresholds. RESULTS: Of the 1150 patients included in this study, 820 (71.3%) had no history of CAD, 97 (8.4%) had index AMI and 123 (10.7%) had 30-day MACE. In patients with no prior history of CAD, HEAR ≤ 1 identified 202 (24.6%) of patients as very low risk for 30-day MACE with 98.4% (95% CI 91.6-99.9%) sensitivity. Among all patients, HEAR ≤ 1 identified 202 (17.6%) patients as very low risk for 30-day MACE with 99.2% (95% CI 95.6-99.9%) sensitivity. CONCLUSIONS: A HEAR score ≤ 1 can identify more than 17% of all patients as very low risk for index AMI and 30-day MACE and unlikely to benefit from troponin testing. Broad implementation of this strategy could lead to significant resource savings.
Authors: Simon A Mahler; Kristin M Lenoir; Brian J Wells; Gregory L Burke; Pamela W Duncan; L Douglas Case; David M Herrington; Jose-Franck Diaz-Garelli; Wendell M Futrell; Brian C Hiestand; Chadwick D Miller Journal: Circulation Date: 2018-11-27 Impact factor: 29.690
Authors: Jessica Laureano-Phillips; Richard D Robinson; Subhash Aryal; Somer Blair; Damalia Wilson; Kellie Boyd; Chet D Schrader; Nestor R Zenarosa; Hao Wang Journal: Ann Emerg Med Date: 2019-02-02 Impact factor: 5.721
Authors: Jason P Stopyra; Robert F Riley; Brian C Hiestand; Gregory B Russell; James W Hoekstra; Cedric W Lefebvre; Bret A Nicks; David M Cline; Kim L Askew; Stephanie B Elliott; David M Herrington; Gregory L Burke; Chadwick D Miller; Simon A Mahler Journal: Acad Emerg Med Date: 2018-07-19 Impact factor: 3.451
Authors: James E Andruchow; Timothy Boyne; Isolde Seiden-Long; Dongmei Wang; Shabnam Vatanpour; Grant Innes; Andrew D McRae Journal: CJEM Date: 2020-09 Impact factor: 2.410
Authors: Thomas Moumneh; Benjamin C Sun; Aileen Baecker; Stacy Park; Rita Redberg; Maros Ferencik; Ming-Sum Lee; Delphine Douillet; Pierre-Marie Roy; Adam L Sharp Journal: Am J Med Date: 2020-10-27 Impact factor: 4.965
Authors: Dennis T Ko; Neil D Dattani; Peter C Austin; Michael J Schull; Joseph S Ross; Harindra C Wijeysundera; Jack V Tu; Maria Eberg; Maria Koh; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2018-11
Authors: Helen E Hughes; Thomas C Hughes; Roger Morbey; Kirsty Challen; Isabel Oliver; Gillian E Smith; Alex J Elliot Journal: Emerg Med J Date: 2020-09-18 Impact factor: 2.740
Authors: James E Andruchow; Timothy Boyne; Grant Innes; Shabnam Vatanpour; Isolde Seiden-Long; Dongmei Wang; Eddy Lang; Andrew D McRae Journal: CJC Open Date: 2019-08-27